Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary J Schiller

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Blood|November 27, 2010
When a gold standard is made of tinGary J Schiller
Hematology. American Society of Hematology. Education Program|December 10, 2013
High-risk acute myelogenous leukemia: treatment today ... and tomorrowGary J Schiller
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 4, 2014
Allogeneic transplantation as therapy for acute myelogenous leukemia in the elderlyGary J Schiller
Leukemia & Lymphoma|January 18, 2014
Evolving treatment strategies in patients with high-risk acute myeloid leukemiaGary J Schiller
Acta Haematologica|October 8, 2015
High-Intensity Induction in the ElderlyGary J Schiller
Leukemia|June 25, 2026
The case for prospective MEN1 surveillance in the era of sequential menin inhibitor therapyChristopher Markosian, Gary J Schiller
International Journal of Hematology|January 24, 2019
Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literatureDaria Gaut, Gary J Schiller
Hematology (Amsterdam, Netherlands)|September 12, 2013
MyelodysplasiaGary J Schiller, Nicholas Reese
Expert Review of Anticancer Therapy|January 17, 2024
Considerations regarding maintenance therapy for acute myeloid leukemia in remissionGary J Schiller, Vlad Kustanovich
Blood Reviews|September 12, 2021
Beyond steroids: A systematic review and proposed solutions to managing acute graft-versus-host disease in adolescents and young adultsBrian D Friend, Gary J Schiller
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Blood|November 27, 2010
When a gold standard is made of tinGary J Schiller
Hematology. American Society of Hematology. Education Program|December 10, 2013
High-risk acute myelogenous leukemia: treatment today ... and tomorrowGary J Schiller
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 4, 2014
Allogeneic transplantation as therapy for acute myelogenous leukemia in the elderlyGary J Schiller
Leukemia & Lymphoma|January 18, 2014
Evolving treatment strategies in patients with high-risk acute myeloid leukemiaGary J Schiller
Acta Haematologica|October 8, 2015
High-Intensity Induction in the ElderlyGary J Schiller
Leukemia|June 25, 2026
The case for prospective MEN1 surveillance in the era of sequential menin inhibitor therapyChristopher Markosian, Gary J Schiller
International Journal of Hematology|January 24, 2019
Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literatureDaria Gaut, Gary J Schiller
Hematology (Amsterdam, Netherlands)|September 12, 2013
MyelodysplasiaGary J Schiller, Nicholas Reese
Expert Review of Anticancer Therapy|January 17, 2024
Considerations regarding maintenance therapy for acute myeloid leukemia in remissionGary J Schiller, Vlad Kustanovich
Blood Reviews|September 12, 2021
Beyond steroids: A systematic review and proposed solutions to managing acute graft-versus-host disease in adolescents and young adultsBrian D Friend, Gary J Schiller
Pageof 11